Cite
MLA Citation
A ABBAS et al.. “P01.01 A Phase 1a/1b dose-escalation study of intravenously administered SB 11285 alone and in combination with nivolumab in patients with advanced solid tumors.” Journal for immunotherapy of cancer, vol. 8, n.d., pp. A7–A8. http://access.bl.uk/ark:/81055/vdc_100177566510.0x000003